Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT05098821

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

Led by Charite University, Berlin, Germany · Updated on 2024-08-21

25

Participants Needed

1

Research Sites

378 weeks

Total Duration

On this page

Sponsors

C

Charite University, Berlin, Germany

Lead Sponsor

S

Sanofi

Collaborating Sponsor

AI-Summary

What this Trial Is About

Currently, patients with moderate to severe atopic dermatitis are treated with dupilumab if unresponsive to topical treatment. However, not all patients who suffer from atopic dermatitis respond similarly to this treatment. Pattern recognition of immune cells (PRI) is an efficient method to screen patients to allow a more personalized therapy. The main aim of this scientific explorative study is to unravel the changes in peripheral blood immune cell compositions in patients with atopic eczema undergoing dupilumab treatment. This allows the identification of phenotypes of treatment responders and non-responders and possible approaches of treatment modifications for non-responders.

CONDITIONS

Official Title

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 and above
  • Diagnosis of atopic dermatitis for 651 year
  • Inadequate response to treatment with topical medications
  • Confirmed dupilumab treatment
Not Eligible

You will not qualify if you...

  • Age below 18
  • Known or suspected allergy or reaction to any component of the dupilumab formulation
  • Known active allergic or irritant contact dermatitis that is likely to interfere with the assessment of the severity of AD
  • Severe conjunctivitis or blepharitis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dpt of Dermatology and Allergology, Charité - Universitätsmedizin Berlin

Berlin, Germany, 10117

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | DecenTrialz